Muhammad Yazid Jalaludin

Liraglutide in Children and Adolescents with Type 2 Diabetes

William V. Tamborlane, Margarita Barrientos‐Pérez, Udi Fainberg et al. · New England Journal of Medicine · 2019 · 333 citations · Full text

Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial

Kevan C. Herold, Stephen E. Gitelman, Steven M. Willi et al. · Diabetologia · 2012 · 153 citations

Type 1, Diabetes Management, Teplizumab Treatment +8

Triglyceride to HDL-C Ratio is Associated with Insulin Resistance in Overweight and Obese Children

Nur Ahmad Kamil Zati Iwani, Muhammad Yazid Jalaludin, Ruziana Mona Wan Mohd Zin et al. · Scientific Reports · 2017 · 133 citations · Full text

Liraglutide for Children 6 to <12 Years of Age with Obesity — A Randomized Trial

Claudia K. Fox, Margarita Barrientos‐Pérez, Eric M. Bomberg et al. · New England Journal of Medicine · 2024 · 82 citations

Metabolic syndrome among 13 year old adolescents: prevalence and risk factors

AA Fadzlina, Fatimah Harun, MY Nurul Haniza et al. · BMC Public Health · 2014 · 72 citations · Full text